openPR Logo
Press release

Irritable Bowel Syndrome Treatment Market Size will Observe Substantial Growth by 2022

02-17-2018 09:55 AM CET | Health & Medicine

Press release from: Persistence Market Research

Irritable Bowel Syndrome Treatment Market Size will Observe

Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome affects the large intestine. Irritable bowel syndrome is associated with malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood test and endoscopy are normally performed to detect this syndrome. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/9938

The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined diagnosis criteria and exploration of novel therapeutic classes by the key market players. Additionally, change in lifestyle and eating habits increases the incidence of this disorder that may escalate the use of this treatment and hence drive the market growth. However, lack of specific treatment which treat all the symptoms of this disorder may restrain the growth of this market. In addition, higher competition among the key players in terms of pricing is anticipated to hamper overall growth of this market.

Depending on geographic regions, global irritable bowel syndrome treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Geographically, North America dominates the global irritable bowel syndrome treatment market. High degree of therapeutic needs and penetration of generic drugs in North American market is anticipated to drive the growth of this market. Meanwhile, Europe is considered as the second largest market owing to the large patient population undergoing diagnosis of irritable bowel syndrome coupled with the increasing demand for treatment. Launch of novel drugs with improved efficacy which provide sustained relief from irritable bowel syndrome in APAC region primarily drives the growth of this market. In addition, growing awareness regarding chronic nature of irritable bowel syndrome among the people will further drive the growth of this market in APAC region.

Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population, increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the forecast period.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/9938

Various key players dominating the global irritable bowel syndrome treatment market comprise Valeant Pharmaceuticals International Inc., Sucampo Pharmaceuticals, Inc., Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, Inc., GlaxoSmithKline plc. Allergan Plc. among others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Irritable Bowel Syndrome Treatment Market Size will Observe Substantial Growth by 2022 here

News-ID: 947111 • Views:

More Releases from Persistence Market Research

Highly Visible Packaging Market to Reach US$82.6 Bn by 2031, Driven by 7.8% CAGR Growth - Persistence Market Research
Highly Visible Packaging Market to Reach US$82.6 Bn by 2031, Driven by 7.8% CAGR …
➤Overview of the Market The global highly visible packaging market is gaining strong momentum as consumer behavior increasingly shifts toward products that offer both convenience and visual appeal. According to Persistence Market Research, the market is projected to grow from US$48.8 Bn in 2024 to US$82.6 Bn by 2031, reflecting a robust CAGR of 7.8% during the forecast period. Highly visible packaging is designed to enhance product visibility, often through features
Cosmetics and Perfumery Glass Bottles Market to Reach US$37.2 Bn by 2031 with 5.6% CAGR - Persistence Market Research
Cosmetics and Perfumery Glass Bottles Market to Reach US$37.2 Bn by 2031 with 5. …
➤Overview of the Market The cosmetics and perfumery glass bottles market plays a vital role in the global packaging industry, catering to the rising demand for premium beauty and fragrance products. Glass bottles are preferred over plastic due to their luxurious appeal, durability, and recyclability, making them the go-to choice for cosmetic and perfume manufacturers. According to the latest study by Persistence Market Research, the global market is projected to grow
Bakery Cases Market to Reach US$1.5 Bn by 2031, Expanding at 6.0% CAGR - Persistence Market Research
Bakery Cases Market to Reach US$1.5 Bn by 2031, Expanding at 6.0% CAGR - Persist …
➤Overview of the Market The bakery cases market plays an essential role in the global food retail and foodservice industry, as it ensures the safe display, preservation, and presentation of bakery products such as bread, cakes, pastries, and desserts. These cases are vital not only for extending the shelf life of baked goods but also for enhancing their visual appeal, which significantly influences consumer purchase behavior. As bakeries, cafés, supermarkets, and
Mining Waste Management Market to Reach US$307.53 Bn by 2031, Driven by Sustainability and Regulation
Mining Waste Management Market to Reach US$307.53 Bn by 2031, Driven by Sustaina …
➤Overview of the Market The mining waste management market plays a crucial role in addressing one of the most pressing issues of the global mining industry: the sustainable disposal and utilization of mining by-products. These wastes include tailings, slag, and waste rock generated during mineral extraction and processing. With rising environmental concerns, stricter government regulations, and the growing need for responsible mining, the demand for structured waste management systems is on

All 5 Releases


More Releases for Irritable

Irritable Bowel Syndrome Medication Market Massive Growth opportunity Ahead
Exactitude Consultancy., Ltd. announces the release of the report "Global Irritable Bowel Syndrome Medication Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.
Irritable Bowel Syndrome (IBS) Treatment Market Grows Amidst Escalating Prevalen …
What combination of drivers is leading to accelerated growth in the irritable bowel syndrome (ibs) treatment market? The increase in irritable bowel syndrome (IBS) commonness is anticipated to spur the advancement of the IBS treatment market in the future. IBS is a persistent condition that impacts the large intestine. This uptick in IBS occurrence can be attributed to unhealthy lifestyles, poor dietary practices, exposure to pollutants, and elevated stress levels. The
Irritable Bowel Syndrome Treatment Market | $2 Billion by 2026
The market for treating irritable bowel syndrome (IBS) has witnessed significant growth in recent years. In 2018, the estimated value of the IBS treatment market was $1,071 million. However, with increasing awareness and advancements in medical research, the market is projected to reach a staggering $2,012 million by 2026. This represents a remarkable compound annual growth rate (CAGR) of 8.2% during the forecast period from 2019 to 2026. Irritable bowel syndrome
Global Irritable Bowel Syndrome Treatment Market Strategical Analysis Report 202 …
The primary purpose of the statistical analysis is to use data analysis and descriptive statistics. It helps to summarize data from a sample using indexes like mean or standard deviation and inferential statistics. This report includes information and statistics on price levels, location of the product, and demand for the product. The best thing about the statistical analysis report is that it allows businesses to make decisions in terms of
Irritable Bowel Syndrome (IBS) Treatment Market: Increasing Prevalence of Irrita …
The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth. IBS is a common chronic condition that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than
Ayurvedic Cure For Irritable Bowel Syndrome (IBS) Without Operation
The Grocare is a leading natural solution provider for chronic lifestyle diseases – Irritable bowel syndrome (IBS), is a gift of enterprise, and commitment to quality and modern-day buyers’ changing needs. Grocare conforms to stringent quality-related compliances and cost-efficient processes in all aspects of formulation and production. At Grocare, we use natural ingredients developed over the years of research and development. It is FDA certified, safe to use, and affordable